stockrow
Friday 6 November 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
179.61
2.78
−1.52%
Follow ENSG
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
28.99 | 25.26 | 30.49 | 23.11 | 23.45 | 22.86 | 21.92 | 20.33 | 27.03 | 20.97 |
Piotroski F-Score |
7 | 6 | 6 | 5 | 6 | 7 | 5 | 7 | 5 | 4 |
Altman Z-Score |
3.57 | 3.30 | 2.97 | 3.03 | 3.13 | 2.90 | 2.16 | 4.15 | 3.11 | 3.59 |
P/S ratio |
1.97 | 1.77 | 1.71 | 1.71 | 1.74 | 1.62 | 1.19 | 1.07 | 0.69 | 0.63 |
P/FCF ratio |
26.93 | 39.84 | 23.61 | 26.79 | 21.99 | 12.05 | 18.93 | 11.40 | 39.17 | 21.28 |
Altman Z″-Score (non-manufacturers) |
2.75 | 2.78 | 2.38 | 2.44 | 2.31 | 1.85 | 1.50 | 2.96 | 2.76 | 3.08 |
Beneish M-Score |
(2.57) | (2.30) | (2.51) | (2.25) | (2.53) | (2.94) | (1.78) | (3.13) | (2.65) | (2.44) |
P/Operating CF |
54.46 | 74.93 | 74.90 | 103.38 | 64.26 | 42.73 | 40.52 | 35.30 | 67.58 | 388.14 |
Dividend Safety Score |
92 | — | — | — | — | — | — | — | — | — |
P/B ratio |
4.47 | 4.09 | 4.27 | 4.15 | 4.48 | 4.76 | 3.70 | 3.11 | 2.20 | 2.28 |
Price to Tangible BV |
4.69 | 4.34 | 4.52 | 4.45 | 4.79 | 5.15 | 4.07 | 3.60 | 3.05 | 3.10 |
EV/Sales |
1.89 | 1.68 | 1.61 | 1.66 | 1.70 | 1.57 | 1.31 | 1.18 | 0.85 | 0.76 |
EV/EBITDA |
18.00 | 16.11 | 18.28 | 13.91 | 14.04 | 13.50 | 14.76 | 15.93 | 15.79 | 9.62 |
EV/Operating CF |
16.93 | 20.58 | 15.95 | 18.38 | 16.16 | 10.08 | 13.92 | 9.87 | 17.08 | 17.11 |
EV/FCF |
25.77 | 37.82 | 22.22 | 25.87 | 21.42 | 11.63 | 20.89 | 12.64 | 48.33 | 25.63 |
Quick Ratio |
1.35 | 1.48 | 1.38 | 1.27 | 1.16 | 0.99 | 1.12 | 1.08 | 1.42 | 1.48 |
Current Ratio |
1.42 | 1.56 | 1.42 | 1.34 | 1.22 | 1.04 | 1.20 | 1.29 | 1.63 | 1.58 |
Net Debt/EBITDA |
(0.81) | (0.86) | (1.15) | (0.50) | (0.38) | (0.48) | 1.38 | 1.56 | 2.99 | 1.63 |
Debt/Assets |
2.59% | 3.12% | 3.58% | 4.44% | 5.50% | 4.54% | 13.88% | 20.58% | 28.39% | 28.33% |
Debt/Equity |
0.06 | 0.08 | 0.10 | 0.12 | 0.15 | 0.14 | 0.50 | 0.40 | 0.63 | 0.62 |
Asset Turnover |
1.00 | 0.96 | 0.98 | 0.96 | 0.97 | 0.98 | 1.15 | 1.54 | 1.52 | 1.89 |
Operating CF/Net income |
1.64 | 1.17 | 1.80 | 1.21 | 1.42 | 2.19 | 1.74 | 2.28 | 1.97 | 1.48 |
Capex/Depreciation |
(1.84) | (1.86) | (1.45) | (1.24) | (1.19) | (0.90) | (1.23) | (1.02) | (1.20) | (0.62) |
Interest Coverage |
53.24 | 43.24 | 31.58 | 33.24 | 38.03 | 23.84 | 8.25 | 5.59 | 3.17 | 12.87 |
| 16.88% | 17.85% | 15.25% | 19.79% | 21.16% | 23.13% | 17.57% | 16.76% | 8.43% | 11.27% | |
| 6.79% | 6.74% | 5.49% | 7.13% | 7.21% | 6.95% | 6.24% | 8.09% | 3.85% | 5.72% | |
ROIC |
14.73% | 15.35% | 14.25% | 17.33% | 18.04% | 20.40% | 8.90% | 6.59% | 3.56% | 8.51% |
Return on Tangible Assets |
16.58% | 17.47% | 14.93% | 18.86% | 19.37% | 21.34% | 13.23% | 13.44% | 5.96% | 8.24% |
Average Days of Receivables |
45.97 | 48.82 | 47.47 | 49.27 | 45.67 | 46.34 | 55.38 | 52.40 | 60.53 | 53.91 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
5.33% | 5.28% | 7.05% | 5.25% | 5.78% | 5.40% | 5.44% | 5.16% | 4.64% | 4.18% |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.07 | 0.13 | 0.12 |
Share Based Compensation of Revenue |
0.95% | 0.85% | 0.82% | 0.75% | 0.71% | 0.60% | 0.56% | 0.48% | 0.49% | 0.55% |
Graham Net Nets |
(0.20) | (0.22) | (0.26) | (0.27) | (0.26) | (0.29) | (0.53) | (0.12) | (0.21) | (0.20) |
Graham Number |
72.62 | 62.00 | 47.69 | 45.76 | 38.86 | 33.15 | 23.91 | 21.47 | 13.29 | 14.24 |
Earnings Yield |
3.45% | 3.96% | 3.28% | 4.33% | 4.26% | 4.37% | 4.56% | 4.92% | 3.70% | 4.77% |
Free Cash Flow Yield |
3.71% | 2.51% | 4.23% | 3.73% | 4.55% | 8.30% | 5.28% | 8.77% | 2.55% | 4.70% |
Revenue per Share |
88.26 | 75.20 | 66.94 | 55.12 | 48.22 | 44.96 | 38.10 | 33.73 | 31.38 | 32.73 |
Operating CF per Share |
9.85 | 6.13 | 6.76 | 4.97 | 5.06 | 6.99 | 3.60 | 4.04 | 1.56 | 1.46 |
Capex per Share |
(3.38) | (2.79) | (1.91) | (1.44) | (1.24) | (0.93) | (1.20) | (0.89) | (1.01) | (0.49) |
Free Cash Flow per Share |
6.47 | 3.34 | 4.86 | 3.53 | 3.82 | 6.05 | 2.40 | 3.16 | 0.55 | 0.98 |
Cash per Share |
9.99 | 9.30 | 9.46 | 6.04 | 5.06 | 4.68 | 1.44 | 0.76 | 1.09 | 1.37 |
Shareholders Equity per Share |
39.00 | 32.48 | 26.88 | 22.75 | 18.75 | 15.31 | 12.28 | 11.58 | 9.82 | 9.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
39.00 | 32.48 | 26.88 | 22.75 | 18.75 | 15.31 | 12.28 | 11.58 | 9.82 | 9.11 |
Free Cash Flow |
370.71 | 188.95 | 270.49 | 193.60 | 207.88 | 323.44 | 128.09 | 164.18 | 28.11 | 49.31 |
Working Capital |
377.96 | 414.20 | 312.18 | 199.05 | 116.64 | 20.56 | 67.91 | 78.85 | 142.26 | 121.93 |
Capital Expenditures |
(193.56) | (158.24) | (106.18) | (78.91) | (67.80) | (49.91) | (64.13) | (46.12) | (51.43) | (24.57) |
Net Current Asset Value |
(1,955.84) | (1,671.30) | (1,633.29) | (1,422.10) | (1,189.20) | (1,144.39) | (1,294.68) | (231.55) | (234.30) | (206.67) |
EV/EBIT |
22.46 | 19.94 | 23.53 | 16.87 | 17.11 | 16.86 | 20.72 | 24.44 | 31.46 | 13.76 |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 |
Price to Operating Income |
23.47 | 21.01 | 25.01 | 17.48 | 17.56 | 17.46 | 18.77 | 22.04 | 25.50 | 11.43 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 |
Cash ROIC |
12.57% | 7.52% | 12.44% | 11.17% | 14.29% | 27.32% | 12.07% | 18.55% | 3.24% | 6.06% |
Accounts Receivable Turnover |
8.38 | 8.08 | 8.35 | 8.21 | 8.29 | 7.83 | 7.26 | 6.79 | 6.27 | 7.30 |
Accounts Payable Turnover |
43.39 | 37.47 | 36.95 | 37.09 | 39.61 | 41.62 | 41.16 | 38.94 | 36.53 | 39.09 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
8.34 | 10.05 | 10.79 | 11.22 | 9.82 | 9.31 | 9.40 | 9.47 | 10.00 | 9.71 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
603.44 | 527.47 | 446.74 | 368.58 | 316.90 | 307.02 | 280.45 | 258.49 | 254.75 | 226.73 |
Average Payables |
98.14 | 95.88 | 84.95 | 67.60 | 54.51 | 47.94 | 42.41 | 39.44 | 39.02 | 37.51 |
Average Assets |
5,066.16 | 4,423.45 | 3,814.78 | 3,151.32 | 2,698.10 | 2,453.74 | 1,771.93 | 1,142.20 | 1,051.73 | 874.39 |
Average Common Equity |
2,037.63 | 1,668.87 | 1,373.06 | 1,135.26 | 919.97 | 737.19 | 629.24 | 551.20 | 480.28 | 443.74 |
Columns are period end dates · fundamentals updated 2 Nov 2026